Jump Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Jump Financial’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,000	Closed	-$263K	–	2162
2022 Q3	$263K	Buy	32,000 +1,432	+5%	+$11K	0.01%	1215
2022 Q2	$201K	Buy	+30,568	New	+$148K	0.01%	1315
2022 Q1	–	Sell	-24,181	Closed	-$113K	–	2076
2021 Q4	$113K	Buy	+24,181	New	+$150K	0.01%	1212
2021 Q3	–	Sell	-50,900	Closed	-$336K	–	1679
2021 Q2	$336K	Buy	+50,900	New	+$351K	0.03%	622

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Jump Financial's AVEO Position: Q4 2022 in Review

Jump Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 32,000 shares — an estimated $263K sold.

Jump Financial first reported a position in AVEO in Q2 2021 and held it in 4 quarters. The position peaked at $336K in Q2 2021. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

Jump Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Jump Financial sold 32,000 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $263K.
Jump Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 4 quarters.
Jump Financial's AVEO Pharmaceuticals, Inc. position peaked at $336K in Q2 2021.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on Jump Financial's 13F filing for Q4 2022, filed 14 Feb 2023.